Search

MSK 患者仍将留在网络内，继续接受世界一流的癌症照护服务。

… Monday, December 23, 2024 MSK 患者仍将留在网络内，继续接受世界一流的癌症照护服务 位于纽约的 Anthem Blue Cross and Blue Shield 与 Memorial Sloan Kettering Cancer Center (MSK) 今天宣布，两家机构已达成一项新的多年期协议，为 Anthem 旗下会员提供在纽约及周边地区 MSK 医院、门诊护理中心和医生办公室继续就医的机会。 根据新合同，Anthem 雇主医疗计划的成员将可以在 MSK 医生和设施处不间断地接受网络内就诊。 MSK 还将继续为 Anthem 的 Medicaid 和基本健保计划

Dr. Thompson and MSK are being recognized with this prestigious award for leadership during the ongoing COVID-19 pandemic.

… Wednesday, October 21, 2020 Memorial Sloan Kettering (MSK) President and CEO,  Craig B. Thompson, MD , has been awarded Columbia Business School’s Deming Cup for Operational Excellence. Dr. Thompson and MSK are being recognized with this prestigious award for leadership during the ongoing COVID-19 pandemic

New research from MSK offers a window into patients’ complex decision-making around adjuvant therapy, explores the promise of engineered CAR T cells, highlights the success of a summer research program to support groups underrepresented in science, and more.

… Thursday, February 23, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute — a hub for basic science and translational research at MSK — offers a window into patients’ complex decision-making around adjuvant therapy; explores the promise of engineered

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Wednesday, July 15, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: The Pershing Square Foundation Awards $3 Million to SARS-CoV-2 Research Projects Benjamin Greenbaum, PhD Matthew Hellmann, MD Jedd Wolchok, MD Christine Mayr, MD, PhD Santosha Vardhana

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

… Friday, November 2, 2012 Summary Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer. Ping Chi , a member of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program (HOPP) , is a laboratory investigator

Memorial Sloan Kettering social worker Melissa Stewart has been awarded the Assocation of Oncology Social Work (AOSW)’s Dennis Roth Neuro-Oncology Social Worker of the Year for 2010. She will be honored at the AOSW conference in Phoenix, Arizona on May 2, 2010.

… Thursday, March 25, 2010 Memorial Sloan Kettering social worker Melissa Stewart has been awarded the Assocation of Oncology Social Work (AOSW)’s Dennis Roth Neuro-Oncology Social Worker of the Year for 2010. She will be honored at the AOSW conference in Phoenix, Arizona on May 2, 2010.

Meet Monika Shah, MD, infectious disease specialist at Memorial Sloan Kettering.

… Friday, April 2, 2021 Monika Shah, MD , infectious disease specialist, Vice Chair of Education in the Department of Medicine, and Chair of Memorial Sloan Kettering’s Graduate Medical Education Committee, is everything you’d want in a good friend. She’s warm, compassionate, and easy to talk to — someone

Memorial Sloan Kettering Cancer Center has announced the appointment of David R. Jones as Chief of the Thoracic Service in the Department of Surgery, and Charles M. Rudin as Chief of the Thoracic Oncology Service, Division of Solid Tumor Oncology, in the Department of Medicine.

… Thursday, September 5, 2013 Memorial Sloan Kettering Cancer Center (MSKCC) has announced the appointment of David R. Jones as Chief of the Thoracic Service in the Department of Surgery, and Charles M. Rudin as Chief of the Thoracic Oncology Service, Division of Solid Tumor Oncology, in the Department

Grief can feel all-consuming, but those intense feelings don’t last forever.

… Wednesday, June 26, 2024 One of life’s most difficult experiences is losing a loved one, and grief doesn’t necessarily follow a straight path through stages that neatly fit into boxes. Though each person’s grief is as unique as their fingerprints, experts have identified some thoughts and feelings common

Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.

… Monday, December 16, 2024 Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan Kettering are seen posing outdoors with the trial’s two principal investigators. Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan